National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov

NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
NCI Drug Dictionary
Page Options
Print This Page
More NCI Dictionaries
Dictionary of Cancer Terms

Glossary of Statistical Terms

NCI Dictionary of Genetics Terms

Terminology Resources
Quit Smoking Today
Search for
# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All

recombinant interleukin-18
A recombinant therapeutic agent which is chemically identical to or similar to the endogenous cytokine interleukin-18 (IL-18). Produced primarily by macrophages, IL-18 induces the production of interferon-gamma (IFN-gamma), and enhances the activity of natural killer (NK) and cytotoxic T lymphocytes (CTL). As a potential immunotherapeutic agent, IL-18 displays antitumor effects in vitro and in animal models. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)

Synonyms:IFN-gamma-inducing factor
interferon-gamma-inducing factor
Abbreviation:IL-18
Code name:SB-485232



Previous:recombinant interferon gamma, recombinant interleukin-1-alpha, recombinant interleukin-1-beta, recombinant interleukin-11, recombinant interleukin-12
Next:recombinant interleukin-3, recombinant interleukin-4, recombinant interleukin-6, recombinant interleukin-7, recombinant macrophage colony-stimulating factor

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov